ARTICLE | Company News
WuXi to supply manufacturing for Adagene's clinical trials
March 23, 2018 6:33 PM UTC
WuXi Biologics Inc. (HKSE:2269) will support manufacturing of products from Adagene Inc. (Suzhou, China) for use in Chinese and U.S. clinical trials...